Trevi Therapeutics, Inc. (TRVI)
13.14
-0.04
(-0.30%)
USD |
NASDAQ |
Oct 07, 16:00
13.14
0.00 (0.00%)
After-Hours: 20:00
Trevi Therapeutics Price to Book Value : 5.821 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 5.821 |
| October 06, 2026 | 5.838 |
| October 05, 2026 | 6.078 |
| October 02, 2026 | 6.162 |
| October 01, 2026 | 6.282 |
| September 30, 2026 | 6.344 |
| September 29, 2026 | 6.388 |
| September 28, 2026 | 6.379 |
| September 25, 2026 | 6.383 |
| September 24, 2026 | 6.501 |
| September 23, 2026 | 6.406 |
| September 22, 2026 | 6.751 |
| September 21, 2026 | 6.596 |
| September 18, 2026 | 6.622 |
| September 17, 2026 | 6.738 |
| September 16, 2026 | 6.649 |
| September 15, 2026 | 6.662 |
| September 14, 2026 | 7.039 |
| September 11, 2026 | 7.043 |
| September 10, 2026 | 7.048 |
| September 09, 2026 | 7.371 |
| September 08, 2026 | 7.451 |
| September 04, 2026 | 7.646 |
| September 03, 2026 | 7.557 |
| September 02, 2026 | 7.553 |
| Date | Value |
|---|---|
| September 01, 2026 | 7.340 |
| August 31, 2026 | 7.354 |
| August 28, 2026 | 7.438 |
| August 27, 2026 | 7.956 |
| August 26, 2026 | 7.938 |
| August 25, 2026 | 7.952 |
| August 24, 2026 | 8.009 |
| August 21, 2026 | 7.956 |
| August 20, 2026 | 8.084 |
| August 19, 2026 | 8.332 |
| August 18, 2026 | 8.346 |
| August 17, 2026 | 8.186 |
| August 14, 2026 | 8.177 |
| August 13, 2026 | 8.040 |
| August 12, 2026 | 7.854 |
| August 11, 2026 | 7.885 |
| August 10, 2026 | 7.885 |
| August 07, 2026 | 8.200 |
| August 06, 2026 | 8.195 |
| August 05, 2026 | 8.262 |
| August 04, 2026 | 8.306 |
| August 03, 2026 | 7.929 |
| July 31, 2026 | 8.084 |
| July 30, 2026 | 8.151 |
| July 29, 2026 | 8.014 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.767 |
| Corcept Therapeutics, Inc. | 18.29 |
| Veru, Inc. | 1.478 |
| Johnson & Johnson | 7.325 |
| Eli Lilly & Co. | 33.03 |
Price to Book Value Related Metrics
| Price | 13.14 |
| Earnings Yield | -2.61% |
| Market Cap | 1.871B |